The discovery of functional cannabinoid receptors 2 (CB(2)Rs) in brain suggests a potential new therapeutic target for neurological and psychiatric disorders, However, recent findings in experimental animals appear controversial. Here we report that there are significant species differences in CB2R mRNA splicing and expression, protein sequences, and receptor responses to CB2R ligands in mice and rats. Systemic administration of JWH133, a highly selective CB2R agonist, significantly and dose-dependently inhibited intravenous cocaine self-administration under a fixed ratio (FR) schedule of reinforcement in mice, but not in rats. However, under a progressive ratio (PR) schedule of reinforcement, JWHI33 significantly increased breakpoint for c...
Behavioral and molecular methods were used to study and determine whether there is a link between de...
The type 1 cannabinoid receptor (CB1) modulates numerous neurobehavioral processes and is therefore ...
No pharmacological treatments are yet approved for patients with cocaine use disorders. Cannabidiol,...
We have recently reported the expression of functional cannabinoid CB2 receptors (CB2Rs) in midbrain...
BACKGROUND: Addiction and major depression are mental health problems associated with stressful even...
Addiction and major depression are mental health problems associated with stressful events in life w...
Addiction and major depression are mental health problems associated with stressful events in life w...
Numerous studies have been carried out in the mouse model, investigating the role of the cannabinoid...
Cannabinoid CB2 receptors (CB2Rs) have been recently reported to modulate brain dopamine (DA)-relate...
Genetic and environmental factors are implicated in the etiology of neuropsychiatric diseases. Inbre...
Cannabinoid CB2 receptors (CB2Rs) are expressed in mouse brain dopamine (DA) neurons and are involve...
Emerging evidence suggests that the endocannabinoid system (ECS) is involved in modulating the rewar...
To date, it has been thought that cannabinoid receptors in CNS are primarily of the CB1R subtype, wi...
This article belongs to the Special Issue Molecular Mechanisms Associated with Drug Addiction Vulner...
The type 1 cannabinoid receptor (CB1) modulates numerous neurobehavioral processes and is therefore ...
Behavioral and molecular methods were used to study and determine whether there is a link between de...
The type 1 cannabinoid receptor (CB1) modulates numerous neurobehavioral processes and is therefore ...
No pharmacological treatments are yet approved for patients with cocaine use disorders. Cannabidiol,...
We have recently reported the expression of functional cannabinoid CB2 receptors (CB2Rs) in midbrain...
BACKGROUND: Addiction and major depression are mental health problems associated with stressful even...
Addiction and major depression are mental health problems associated with stressful events in life w...
Addiction and major depression are mental health problems associated with stressful events in life w...
Numerous studies have been carried out in the mouse model, investigating the role of the cannabinoid...
Cannabinoid CB2 receptors (CB2Rs) have been recently reported to modulate brain dopamine (DA)-relate...
Genetic and environmental factors are implicated in the etiology of neuropsychiatric diseases. Inbre...
Cannabinoid CB2 receptors (CB2Rs) are expressed in mouse brain dopamine (DA) neurons and are involve...
Emerging evidence suggests that the endocannabinoid system (ECS) is involved in modulating the rewar...
To date, it has been thought that cannabinoid receptors in CNS are primarily of the CB1R subtype, wi...
This article belongs to the Special Issue Molecular Mechanisms Associated with Drug Addiction Vulner...
The type 1 cannabinoid receptor (CB1) modulates numerous neurobehavioral processes and is therefore ...
Behavioral and molecular methods were used to study and determine whether there is a link between de...
The type 1 cannabinoid receptor (CB1) modulates numerous neurobehavioral processes and is therefore ...
No pharmacological treatments are yet approved for patients with cocaine use disorders. Cannabidiol,...